09:00 AM EDT, 09/15/2025 (MT Newswires) -- Health care stocks were advancing premarket Monday, with the iShares Biotechnology ETF (IBB) rising by 0.7% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.

Novo Nordisk's ( NVO ) obesity treatment drug Wegovy led to increased weight loss in patients during two late-stage clinical trials in which the dose was tripled to 7.2mg, the Financial Times reported. Novo Nordisk ( NVO ) shares were up more than 3% pre-bell.